Study | Trial group (N) | Control group (N) | Interventions | Treatment cycle | Termination of treatment | |
---|---|---|---|---|---|---|
Endostar combined with chemotherapeutic agents | Chemotherapeutic agents alone | |||||
Liu W 2010 [15] | 32 | 32 | Cisplatin 40 mg/m2, 1/week Endostar 30 mg, 1/week | Cisplatin 40 mg/m2, 1/w | 3 weeks | >3 weeks, or pleural effusion disappeared |
Mao L 2011 [16] | 45 | 45 | Cisplatin 40 mg/m2, 1/week Endostar 30 mg, 2/week | Cisplatin 40 mg/m2, 1/7d | 7d/cycle, 2 cycles | >4 cycles, or pleural effusion disappeared |
Li G 2011 [17] | 30 | 30 | Bleomycin 60 mg, 1/week Endostar 30 mg, 1/week | Bleomycin 60 mg, 1/w | 3 weeks | >3 weeks, or pleural effusion disappeared |
Ma E 2012 [18] | 28 | 28 | Cisplatin 40 mg/m2, 1/week Endostar 30 mg, 1/week | Cisplatin 40 mg/m2, 1/w | 4 weeks | >4 weeks, or pleural effusion disappeared |
Yao Q 2012 [19] | 30 | 30 | Nedaplatin 40 mg, 1/week Endostar 45 mg, 1/week | Nedaplatin 40 mg, 1/w | 4 weeks | >4 weeks, or pleural effusion disappeared |
Zheng Q 2013 [20] | 60 | 60 | Cisplatin 30–40 mg, d1–3 Endostar 90 mg, d4 | Cisplatin 30–40 mg d1–3 | 21d/cycle, 1–4 cycles | >4 cycles, or pleural effusion disappeared |
Kang Y 2013 [21] | 45 | 45 | Cisplatin 40 mg, 2/week Endostar 30 mg, 2/week | Cisplatin 40 mg, 2/w | 3 weeks | >3 weeks, or pleural effusion disappeared |
Wen J 2014 [22] | 25 | 29 | Lobaplatin 30 mg/m2, d1 Endostar 30 mg, d1 | Lobaplatin 30 mg/m2, d1 | 4 cycles | >4 cycles, or pleural effusion disappeared |
Yue G 2014 [23] | 43 | 43 | Cisplatin 60 mg, 1/week Endostar 30 mg, 2/week | Cisplatin 60 mg, 1/w | 2–3 weeks | >4 weeks, or pleural effusion disappeared |
Tu J [24] | 45 | 45 | Cisplatin 40 mg/m2, 2/week Endostar 45 mg, 2/week | Cisplatin 40 mg/m2, 2/w | 3 weeks | >3 weeks, or pleural effusion disappeared |
Xu J 2014 [25] | 35 | 35 | Nedaplatin 60 mg, 1/week Endostar 60 mg, 1/week | Nedaplatin 60 mg, 1/w | 4 weeks | >4 weeks, or pleural effusion disappeared |
Wen X 2015 [26] | 68 | 36 | Bleomycin 45 mg, w1 Endostar 45 mg, w2 | Bleomycin 45 mg, 1/7d | 7d/cycle, 2–4 cycles | >2 weeks, or pleural effusion disappeared |
Hu X 2015 [27] | 43 | 41 | Cisplatin 40 mg, 2/week Endostar 60 mg, 2/week | Cisplatin 40 mg, 2/week | 2 weeks | >2 weeks, or pleural effusion disappeared |